Page 182 - ar2010

180 KPJ Healthcare Berhad

(Company No. 247079 M)

Annual Report 2010

In conformance with the Bursa Malaysia Listing Requirements, the following additional information is provided:

1. Utilisation of Proceeds Raised From Corporate Proposal

The proceeds of RM249.0 million raised from the Commercial Papers/Medium Term Notes Programme have been fully utilised in the following manner:

RM’000

CP/MTN

At start of the fnancial year 249,000 Issued during the fnancial year for working capital purposes 0

At end of fnancial year 249,000

2. Treasury Shares

During the fnancial year and after the Share Split, the Company repurchased 10,000 units of RM0.50 each of its issued share capital from the open market at an average selling price of RM2.26 per share. The total consideration paid inclusive of transaction costs, was RM22,765 and was fnanced by internally generated fund. The shares purchased were retained as treasury shares.

There were no treasury shares sold during the year.

3. Options, Warrants or Convertible Securities

On 15 January 2010, the Company has subdivided its existing 211,050,615 ordinary shares of RM1 each into 422,101,230 ordinary shares of RM0.50 each (“Share Split”). After the Share Split, the Company issued bonus shares of up to 105,525,308 new ordinary shares of RM0.50 each, which were credited as fully paid up by the Company, on the basis of one (1) Bonus Shares for every four (4) shares held by the entitled shareholders of the Company after the Share Split (“Bonus Issue”). After the Share Spilt and Bonus Issue, the Company issued up to 131,906,635 free warrants on the basis of one (1) free warrant for every four (4) shares held by the entitled shareholders of the Company after the Share Split and Bonus Issue.

During the fnancial year, 32,281,340 new ordinary shares of RM0.50 each were issued by the Company for cash by virtue of the conversion of warrant at exercise price of RM1.70 per share.

4. American Depository Receipt (ADR) or Global Depository Receipt (GDR) Programme

During the fnancial year, the Company did not issue any ADR or GDR Programme.

5. Impositions of sanctions/penalties

There were no sanctions and/or penalties imposed on the Company and its subsidiaries, Directors or Management by the relevant regulatory bodies.

6. Non-audit Fees

During the fnancial year, the Company only engaged audit services with the external auditor.

7. Profit estimate, forecast or projections

The Company did not make any release on the proft estimate, forecast or projections for the fnancial year.

8. Profit guarantee

There is no proft guarantee given by the Company in respect of the fnancial year.

COMPLIANCE INFORMATION